CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: A pilot study

A. Romigi, M. Bari, C. Liguori, F. Izzi, C. Rapino, M. Nuccetelli, N. Battista, S. Bernardini, D. Centonze, N.B. Mercuri, F. Placidi, M. Maccarrone

Research output: Contribution to journalArticlepeer-review

Cite this